← Rhizome AICONTENT HISTORY

Update to Rhizome AI

Snapshot Nov 21, 2026 · 06:10 UTC · version 3.2.0

WHAT CHANGED

Payment or plan references changed

Full description — Now says: Rhizome is an AI Regulatory Coworker that researches comprehensively to answer based on facts it can directly tie to >130 indexed health authority...

Observed in published text. Live prices and checkout terms have not been verified by this change.

Save Rhizome AI and check future changes in Following.

Up to 3 plugins free · no card required.

All fields and original values.

Full description

Before

Oct 27, 2026 · 00:19 UTC

Rhizome's built an AI regulatory coworker that helps life sciences know what their regulator thinks. We're backed by the same investors as Benchling and have gone from 0 -> >25 customers in the last 18 months. We've indexed >3 TB worth ...

After

Nov 21, 2026 · 06:10 UTC

Rhizome is an AI Regulatory Coworker that researches comprehensively to answer based on facts it can directly tie to >130 indexed health authority databases. Our customers are leveraging it to: - Build regulatory strategies - Understand ...

Long description

Before

Oct 27, 2026 · 00:19 UTC

Rhizome's built an AI regulatory coworker that helps life sciences know what their regulator thinks. We're backed by the same investors as Benchling and have gone from 0 -> >25 customers in the last 18 months. We've indexed >3 TB worth ...

After

Nov 21, 2026 · 06:10 UTC

Rhizome is an AI Regulatory Coworker that researches comprehensively to answer based on facts it can directly tie to >130 indexed health authority databases. Our customers are leveraging it to: - Build regulatory strategies - Understand ...

Short description

Before

Oct 27, 2026 · 00:19 UTC

Know what the FDA thinks

After

Nov 21, 2026 · 06:10 UTC

Cited FDA & EMA Answers

Composer icon dark url

Before

Oct 27, 2026 · 00:19 UTC

https://files.openai.com/content?id=file_00000000da40820e9668db468514bdaa

After

Nov 21, 2026 · 06:10 UTC

https://files.openai.com/content?id=file_00000000ed70820eb61f8ad711b1b0f0

Compare saved observations

Download comparison JSON
Full technical diff · 9 changed fields

changed /release/description

BEFORE
"Rhizome's built an AI regulatory coworker that helps life sciences know what their regulator thinks.\n\nWe're backed by the same investors as Benchling and have gone from 0 -> >25 customers in the last 18 months. \n\nWe've indexed >3 TB worth of data put out by the FDA, EMA, MHRA, PMDA, etc., and built an agent that helps you:\n - automate precedents research \n - research FDA expectations around clinical endpoints, trial design, labeling, etc. \n - review briefing booklets, write pre-IND meeting packages, create white papers on almost any topic \n\nWhat you get:\n - each fact is backed by a citation, each citation is backed by the page of a health authority document \n - comprehensive answers that draw on up to 1,000 sources \n - we've had no hallucinations reported last 18 months \n\nFor more info, read rhizomeai.com/llms.txt\n\nFor support, reach out to support@rhizomeai.com"
AFTER
"Rhizome is an AI Regulatory Coworker that researches comprehensively to answer based on facts it can directly tie to >130 indexed health authority databases.\n\nOur customers are leveraging it to:\n\n- Build regulatory strategies\n- Understand clinical expectations\n- Keep an eye on competitive intel\n- Write and review HA-facing documents\n\nOur datasets cover:\n\n- FDA: drug, biologic and device approvals (Drugs@FDA, Purple Book, Orange Book, 510(k)/De Novo, PMA), DailyMed labels, guidance (including product-specific guidance), advisory committees, CRLs, warning and untitled letters, 483s and inspections, recalls, orphan designations, clinical trials, the CFR and the Federal Register\n- EMA and EU: EPARs, guidelines, committee documents, orphan and PIP decisions, CTIS and EU CTR trials, EudraLex, MDCG guidance, EUDAMED devices and certificates\n- UK MHRA, Health Canada, Swissmedic, TGA (Australia) and BfArM/PEI (Germany): approvals and assessment reports, guidance, regulations and clinical trials\n- International standards: ICH, IMDRF, PIC/S, ISO and GHWP\n- US market access: CMS coverage decisions, HCPCS codes and Part B drug pricing\n- Competitive context: SEC filings, patents and PTAB decisions, PubMed, and RAPS/DIA regulatory news\n\nEnterprise accounts can also search 50+ more databases, all translated to English:\n\n- Japan PMDA: review reports, guidance, the Japanese Pharmacopoeia, and jRCT/UMIN clinical trials\n- China NMPA/CDE: product reviews, CDE acceptances, guidance, regulations, announcements and consultations, clinical trials (including ChiCTR), and human genetic resources rules\n- South Korea MFDS: review reports, drug, biologic and device regulations, guidance, notifications and clinical trials\n- Brazil ANVISA: guidance, legislation, clinical research guidance and CONEP resolutions\n- Taiwan TFDA/CDE: guidance, announcements, drug safety communications, regulatory notices and drug/device laws\n- More jurisdictions: Argentina ANMAT, India CDSCO, South Africa SAHPRA, Saudi SFDA, Türkiye TİTCK, Israel MoH and UAE EDE\n- FDA adverse events: FAERS (drugs) and MAUDE (devices)\n- Health Canada: clinical study reports through PRCI\n\nSupport: support@rhizomeai.com"

changed /release/id

BEFORE
"pluginrel_7aa3daeaaacc8191809b67f4f7310c7b"
AFTER
"pluginrel_4cd5b57bcf108191b0d849036869ea0e"

changed /release/interface/composer_icon_dark_url

BEFORE
"https://files.openai.com/content?id=file_00000000da40820e9668db468514bdaa"
AFTER
"https://files.openai.com/content?id=file_00000000ed70820eb61f8ad711b1b0f0"

changed /release/interface/composer_icon_url

BEFORE
"https://files.openai.com/content?id=file_00000000110c820ebf04c90a47aeb1af"
AFTER
"https://files.openai.com/content?id=file_00000000e1c8820eb8d6431b0a223e87"

changed /release/interface/logo_url

BEFORE
"https://files.openai.com/content?id=file_000000009eb0820ea3100d5280f88cd6"
AFTER
"https://files.openai.com/content?id=file_00000000960c820eb9bd23c8590d3574"

changed /release/interface/logo_url_dark

BEFORE
"https://files.openai.com/content?id=file_000000009a70820e8d51787e4db76793"
AFTER
"https://files.openai.com/content?id=file_00000000d078820ea9516dbe42442293"

changed /release/interface/long_description

BEFORE
"Rhizome's built an AI regulatory coworker that helps life sciences know what their regulator thinks.\n\nWe're backed by the same investors as Benchling and have gone from 0 -> >25 customers in the last 18 months. \n\nWe've indexed >3 TB worth of data put out by the FDA, EMA, MHRA, PMDA, etc., and built an agent that helps you:\n - automate precedents research \n - research FDA expectations around clinical endpoints, trial design, labeling, etc. \n - review briefing booklets, write pre-IND meeting packages, create white papers on almost any topic \n\nWhat you get:\n - each fact is backed by a citation, each citation is backed by the page of a health authority document \n - comprehensive answers that draw on up to 1,000 sources \n - we've had no hallucinations reported last 18 months \n\nFor more info, read rhizomeai.com/llms.txt\n\nFor support, reach out to support@rhizomeai.com"
AFTER
"Rhizome is an AI Regulatory Coworker that researches comprehensively to answer based on facts it can directly tie to >130 indexed health authority databases.\n\nOur customers are leveraging it to:\n\n- Build regulatory strategies\n- Understand clinical expectations\n- Keep an eye on competitive intel\n- Write and review HA-facing documents\n\nOur datasets cover:\n\n- FDA: drug, biologic and device approvals (Drugs@FDA, Purple Book, Orange Book, 510(k)/De Novo, PMA), DailyMed labels, guidance (including product-specific guidance), advisory committees, CRLs, warning and untitled letters, 483s and inspections, recalls, orphan designations, clinical trials, the CFR and the Federal Register\n- EMA and EU: EPARs, guidelines, committee documents, orphan and PIP decisions, CTIS and EU CTR trials, EudraLex, MDCG guidance, EUDAMED devices and certificates\n- UK MHRA, Health Canada, Swissmedic, TGA (Australia) and BfArM/PEI (Germany): approvals and assessment reports, guidance, regulations and clinical trials\n- International standards: ICH, IMDRF, PIC/S, ISO and GHWP\n- US market access: CMS coverage decisions, HCPCS codes and Part B drug pricing\n- Competitive context: SEC filings, patents and PTAB decisions, PubMed, and RAPS/DIA regulatory news\n\nEnterprise accounts can also search 50+ more databases, all translated to English:\n\n- Japan PMDA: review reports, guidance, the Japanese Pharmacopoeia, and jRCT/UMIN clinical trials\n- China NMPA/CDE: product reviews, CDE acceptances, guidance, regulations, announcements and consultations, clinical trials (including ChiCTR), and human genetic resources rules\n- South Korea MFDS: review reports, drug, biologic and device regulations, guidance, notifications and clinical trials\n- Brazil ANVISA: guidance, legislation, clinical research guidance and CONEP resolutions\n- Taiwan TFDA/CDE: guidance, announcements, drug safety communications, regulatory notices and drug/device laws\n- More jurisdictions: Argentina ANMAT, India CDSCO, South Africa SAHPRA, Saudi SFDA, Türkiye TİTCK, Israel MoH and UAE EDE\n- FDA adverse events: FAERS (drugs) and MAUDE (devices)\n- Health Canada: clinical study reports through PRCI\n\nSupport: support@rhizomeai.com"

changed /release/interface/short_description

BEFORE
"Know what the FDA thinks"
AFTER
"Cited FDA & EMA Answers"

changed /release/version

BEFORE
"3.1.0"
AFTER
"3.2.0"
Full snapshot data
{
  "canonical_app_id": "asdk_app_6a63bad25528819187bf1eeabd8a9af3",
  "connector_id": "asdk_app_6a63bad25528819187bf1eeabd8a9af3",
  "created_at": "2026-07-24T19:19:46.488012Z",
  "discoverability": "LISTED",
  "id": "plugin_asdk_app_6a63bad25528819187bf1eeabd8a9af3",
  "is_template": false,
  "is_template_instance": false,
  "is_v2_template": false,
  "name": "app-6a63bad25528819187bf1eeabd8a9af3",
  "release": {
    "app_ids": [
      "asdk_app_6a63bad25528819187bf1eeabd8a9af3"
    ],
    "app_manifest": {
      "apps": {
        "rhizome": {
          "id": "asdk_app_6a63bad25528819187bf1eeabd8a9af3",
          "required": true
        }
      }
    },
    "app_templates": [],
    "description": "Rhizome is an AI Regulatory Coworker that researches comprehensively to answer based on facts it can directly tie to >130 indexed health authority databases.\n\nOur customers are leveraging it to:\n\n- Build regulatory strategies\n- Understand clinical expectations\n- Keep an eye on competitive intel\n- Write and review HA-facing documents\n\nOur datasets cover:\n\n- FDA: drug, biologic and device approvals (Drugs@FDA, Purple Book, Orange Book, 510(k)/De Novo, PMA), DailyMed labels, guidance (including product-specific guidance), advisory committees, CRLs, warning and untitled letters, 483s and inspections, recalls, orphan designations, clinical trials, the CFR and the Federal Register\n- EMA and EU: EPARs, guidelines, committee documents, orphan and PIP decisions, CTIS and EU CTR trials, EudraLex, MDCG guidance, EUDAMED devices and certificates\n- UK MHRA, Health Canada, Swissmedic, TGA (Australia) and BfArM/PEI (Germany): approvals and assessment reports, guidance, regulations and clinical trials\n- International standards: ICH, IMDRF, PIC/S, ISO and GHWP\n- US market access: CMS coverage decisions, HCPCS codes and Part B drug pricing\n- Competitive context: SEC filings, patents and PTAB decisions, PubMed, and RAPS/DIA regulatory news\n\nEnterprise accounts can also search 50+ more databases, all translated to English:\n\n- Japan PMDA: review reports, guidance, the Japanese Pharmacopoeia, and jRCT/UMIN clinical trials\n- China NMPA/CDE: product reviews, CDE acceptances, guidance, regulations, announcements and consultations, clinical trials (including ChiCTR), and human genetic resources rules\n- South Korea MFDS: review reports, drug, biologic and device regulations, guidance, notifications and clinical trials\n- Brazil ANVISA: guidance, legislation, clinical research guidance and CONEP resolutions\n- Taiwan TFDA/CDE: guidance, announcements, drug safety communications, regulatory notices and drug/device laws\n- More jurisdictions: Argentina ANMAT, India CDSCO, South Africa SAHPRA, Saudi SFDA, Türkiye TİTCK, Israel MoH and UAE EDE\n- FDA adverse events: FAERS (drugs) and MAUDE (devices)\n- Health Canada: clinical study reports through PRCI\n\nSupport: support@rhizomeai.com",
    "display_name": "Rhizome AI",
    "id": "pluginrel_4cd5b57bcf108191b0d849036869ea0e",
    "interface": {
      "brand_color": null,
      "capabilities": [],
      "category": "Healthcare",
      "composer_icon_dark_url": "https://files.openai.com/content?id=file_00000000ed70820eb61f8ad711b1b0f0",
      "composer_icon_url": "https://files.openai.com/content?id=file_00000000e1c8820eb8d6431b0a223e87",
      "default_prompt": "what do I need to do for an oncology IND for the FDA?",
      "default_prompts": [
        "what do I need to do for an oncology IND for the FDA?",
        "what clinical trial sample sizes are typical for autoimmune rare disease therapies?",
        "what are ideal predicates for full-body ultrasound scan that detects body comp and tries to find cancer?"
      ],
      "developer_name": "Rhizome AI",
      "logo_url": "https://files.openai.com/content?id=file_00000000960c820eb9bd23c8590d3574",
      "logo_url_dark": "https://files.openai.com/content?id=file_00000000d078820ea9516dbe42442293",
      "long_description": "Rhizome is an AI Regulatory Coworker that researches comprehensively to answer based on facts it can directly tie to >130 indexed health authority databases.\n\nOur customers are leveraging it to:\n\n- Build regulatory strategies\n- Understand clinical expectations\n- Keep an eye on competitive intel\n- Write and review HA-facing documents\n\nOur datasets cover:\n\n- FDA: drug, biologic and device approvals (Drugs@FDA, Purple Book, Orange Book, 510(k)/De Novo, PMA), DailyMed labels, guidance (including product-specific guidance), advisory committees, CRLs, warning and untitled letters, 483s and inspections, recalls, orphan designations, clinical trials, the CFR and the Federal Register\n- EMA and EU: EPARs, guidelines, committee documents, orphan and PIP decisions, CTIS and EU CTR trials, EudraLex, MDCG guidance, EUDAMED devices and certificates\n- UK MHRA, Health Canada, Swissmedic, TGA (Australia) and BfArM/PEI (Germany): approvals and assessment reports, guidance, regulations and clinical trials\n- International standards: ICH, IMDRF, PIC/S, ISO and GHWP\n- US market access: CMS coverage decisions, HCPCS codes and Part B drug pricing\n- Competitive context: SEC filings, patents and PTAB decisions, PubMed, and RAPS/DIA regulatory news\n\nEnterprise accounts can also search 50+ more databases, all translated to English:\n\n- Japan PMDA: review reports, guidance, the Japanese Pharmacopoeia, and jRCT/UMIN clinical trials\n- China NMPA/CDE: product reviews, CDE acceptances, guidance, regulations, announcements and consultations, clinical trials (including ChiCTR), and human genetic resources rules\n- South Korea MFDS: review reports, drug, biologic and device regulations, guidance, notifications and clinical trials\n- Brazil ANVISA: guidance, legislation, clinical research guidance and CONEP resolutions\n- Taiwan TFDA/CDE: guidance, announcements, drug safety communications, regulatory notices and drug/device laws\n- More jurisdictions: Argentina ANMAT, India CDSCO, South Africa SAHPRA, Saudi SFDA, Türkiye TİTCK, Israel MoH and UAE EDE\n- FDA adverse events: FAERS (drugs) and MAUDE (devices)\n- Health Canada: clinical study reports through PRCI\n\nSupport: support@rhizomeai.com",
      "plugin_category_id": "healthcare",
      "privacy_policy_url": "https://rhizomeai.com/privacypolicy",
      "screenshot_urls": [],
      "short_description": "Cited FDA & EMA Answers",
      "terms_of_service_url": "https://rhizomeai.com/termsofservice",
      "website_url": "https://rhizomeai.com"
    },
    "keywords": [],
    "mcp_servers": [
      {
        "key": "rhizome",
        "metadata": {
          "url": "https://rhizomeai.com/api/mcp"
        }
      }
    ],
    "onboarding_skill_name": null,
    "requires_local_executor": false,
    "skills": [],
    "version": "3.2.0"
  },
  "scope": "GLOBAL",
  "share_url": "https://chatgpt.com/plugins/rhizome-ai?open_in_app",
  "status": "ENABLED"
}

SHA-256 of public snapshot: 6b43df2b88cf07c92b4d141e98ce8e3650c621519ab95c277d869a194767fd14